BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Lilly Corporate Center

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME’s principal focus has been on applying its proprietary AMEsystem™ technology platform to the full range of protein therapeutic candidates including antibodies, cytokines, hormones and enzymes to develop novel human biotherapeutic candidates.
Since February 2004, AME has been a wholly-owned subsidiary of Eli Lilly and Company and is an integral part of Lilly’s research organization. Lilly, a leading innovation-driven corporation is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Lilly provides answers – through medicines and information – for some of the world’s most urgent medical needs.

While geographically separate, AME works closely with Lilly colleagues in Indianapolis and around the world, sharing a corporate legacy of integrity and commitment to quality that spans more than a century.


Contact Details:
Mail Drop Code 1854
Indianapolis
Indiana
46285
United States of America
Tel:317-276-2790
Fax:317-276-4878
Email:
WWW:

www.amevolution.com/




Loading...

Recent Publications by Lilly Corporate Center:

Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder.
OBJECTIVE: This study describes and assesses potential hepatobiliary...
30th August, 2008
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Drug Saf. 2008;31(4):345-54.
FGF21 Corrects Obesity in Mice.
FGF21 is a metabolic regulator that provides efficient and durable...
9th August, 2008
Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN Endocrinology. 2008 Aug 7.
DOI Direct Link
Obesity and the use of insulin: a study of patients with type 2 diabetes in the UK.
OBJECTIVE: This analysis examines how obesity affects the prescribing of...
7th August, 2008
Eli Lilly and Co., Lilly Corporate Center, Global Health Outcomes, J Diabetes Complications. 2008 Jul-Aug;22(4):235-40. Epub 2008 Apr 16.
DOI Direct Link
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study.
The objective of this study was to assess the dose-response relationship...
16th July, 2008
Eli Lilly and Company, Lilly Corporate Center, Drop Code 4133, J Clin Psychopharmacol. 2008 Aug;28(4):392-400.
DOI Direct Link
Activation of metabotropic glutamate 5 (mGlu5) receptors induces spontaneous excitatory synaptic currents in layer V pyramidal cells of the rat prefrontal cortex.
Serotonin and norepinephrine, in addition to direct postsynaptic...
16th July, 2008
Lilly Research Laboratories, Psychiatric Disorders Discovery Biology, Neurosci Lett. 2008 Sep 19;442(3):239-43. Epub 2008 Jul 4.
DOI Direct Link

View more Lilly Corporate Center research publications.

BioNews Results for Lilly Corporate Center:

LILLY (ELI) & COMPANY - LLY and Amylin Set Conference Call to Discuss Byetta
Macro World Investor:  Aug 26 2008 12:43PM Matching: lilly corporate center
LLY and Amylin Set Conference Call to Discuss Byetta
London Stock Exchange:  Aug 26 2008 12:35PM Matching: lilly corporate center
LILLY (ELI) & COMPANY - New Study Indicates Taking Cymbalta May Reduce Back Pain
Macro World Investor:  Aug 26 2008 6:09AM Matching: lilly corporate center
Phase Forward Customer Dana-Farber Cancer Institute Recognized by CIO Magazine as a CIO 100 Award Honoree
Oceania:  Aug 26 2008 12:41PM Matching: lilly corporate center
LILLY (ELI) & COMPANY - Cymbalta Receives EU Approval for Anxiety Disorder
SmartBrief:  Aug 22 2008 6:26PM Matching: lilly corporate center
Promote your company here: BioNewsCast - Press Release Distribution

View more Lilly Corporate Center news.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 332 individuals from Lilly Corporate Center using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 358 times since April 2007, the link to the organisation's website has been followed 44 times

Recent Search Terms used to find this page: lilly corporate classes | olanzapine long-acting bipolar | J Clin Psychiatry April 29 2008 e1-e10 | Eli Lilly corporate email contact | Eli Lilly corporate email contact | Cancer Research Lilly Research Laboratories Lilly Corporate Center Indianapolis | Lilly Corporation Center | eli lilly corporate building | Lilly Corporate Ctr Indianapolis IN zip code | Lilly Corporate Center Indianapolis zip | .

Search for more companies in Indianapolis

Search for more companies in Indiana



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Lilly Corporate Center
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.